Ad is loading...
MENU
BOLD Boundless Bio Forecast, Technical & Fundamental Analysis
a developer of gene therapy products for patients with serious rare diseases
Industry Biotechnology
Show more...
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I. Advisor
published General Information
General Information
a developer of gene therapy products for patients with serious rare diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9880 Campus Point Drive
Phone
+1 858 766-9912
Employees
72
Web
https://www.boundlessbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HDDVX | 15.89 | -0.08 | -0.50% |
| Janus Henderson Responsible Intl Div D | |||
| WFGGX | 27.80 | -0.34 | -1.21% |
| First Trust WCM Focused Global Gr Inv | |||
| SUSLX | 14.91 | -0.22 | -1.45% |
| Lazard US Sustainable Equity Open | |||
| TILGX | 29.39 | -0.71 | -2.36% |
| Nuveen Large Cap Growth R6 | |||
| DRGTX | 87.43 | -2.21 | -2.47% |
| Virtus Zevenbergen Technology Inst | |||
BOLD and Stocks
Correlation & Price change
A.I.dvisor tells us that BOLD and ETXPF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOLD and ETXPF's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To BOLD | 1D Price Change % | ||
|---|---|---|---|---|
| BOLD | 100% | -7.10% | ||
| ETXPF - BOLD | 32% Poorly correlated | N/A | ||
| KOD - BOLD | 32% Poorly correlated | +4.34% | ||
| TNXP - BOLD | 32% Poorly correlated | -6.36% | ||
| GRI - BOLD | 25% Poorly correlated | -19.57% | ||
| AKBA - BOLD | 25% Poorly correlated | -3.76% | ||
More | ||||